Transnasal negative pressure therapy for accelerating healing and improving the prognosis of pharyngocutaneous fistula.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
11 2023
Historique:
revised: 04 08 2023
received: 15 05 2023
accepted: 23 08 2023
medline: 23 10 2023
pubmed: 11 9 2023
entrez: 11 9 2023
Statut: ppublish

Résumé

Pharyngocutaneous fistula (PCF) is one of the most common complications of total laryngectomy. This study is to investigate the efficacy of a novel platform called transnasal negative pressure therapy (TNPT) in the management of PCF. We retrospectively reviewed 47 patients who underwent total laryngectomy between April 2015 and February 2021 and developed PCF in our hospital. We focused on the healing rate, dressing change frequency, and healing time between the TNPT and non-TNPT groups. The 2 years overall survival (OS) was compared through the log-rank test. There were 18 patients in the TNPT group and 29 in the non-TNPT group. There was no significant between-group difference in the healing rate (chi-square test). However, the frequency of dressing changes was significantly lower (p < 0.001) and the healing time was significantly shorter (p = 0.0194) in the TNPT group than in the non-TNPT group. The 2-year OS rate was significantly higher in the TNPT group (p = 0.0473, log-rank test). TNPT promoted wound healing after surgery for PCF and improved the 2-year OS rate. This tool is worthy of clinical application and promotion.

Sections du résumé

BACKGROUND
Pharyngocutaneous fistula (PCF) is one of the most common complications of total laryngectomy. This study is to investigate the efficacy of a novel platform called transnasal negative pressure therapy (TNPT) in the management of PCF.
METHODS
We retrospectively reviewed 47 patients who underwent total laryngectomy between April 2015 and February 2021 and developed PCF in our hospital. We focused on the healing rate, dressing change frequency, and healing time between the TNPT and non-TNPT groups. The 2 years overall survival (OS) was compared through the log-rank test.
RESULTS
There were 18 patients in the TNPT group and 29 in the non-TNPT group. There was no significant between-group difference in the healing rate (chi-square test). However, the frequency of dressing changes was significantly lower (p < 0.001) and the healing time was significantly shorter (p = 0.0194) in the TNPT group than in the non-TNPT group. The 2-year OS rate was significantly higher in the TNPT group (p = 0.0473, log-rank test).
CONCLUSION
TNPT promoted wound healing after surgery for PCF and improved the 2-year OS rate. This tool is worthy of clinical application and promotion.

Identifiants

pubmed: 37695059
doi: 10.1002/hed.27505
doi:

Substances chimiques

N,N,N',N'-tetramethyl-N''-(4-nitrophenyl)phosphoric triamide 82720-47-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2809-2818

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Kim DH, Kim SW, Hwang SH. Predictive value of risk factors for pharyngocutaneous fistula after total laryngectomy. Laryngoscope. 2023;133(4):742-754.
Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg. 2006;132(1):67-72.
Šifrer R, Aničin A, Pohar MP, et al. Pharyngocutaneous fistula: the incidence and the risk factors. Eur Arch Otorhinolaryngol. 2016;273(10):3393-3399.
Heo Y, Lee HS, Jung S, et al. Improved early detection models of pharyngocutaneous fistula after total laryngectomy. J Clin Med. 2023;12(5):1-9.
Markou KD, Vlachtsis KC, Nikolaou AC, Petridis DG, Kouloulas AI, Daniilidis IC. Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol. 2004;261(2):61-67.
Fitzgerald C, Davies JC, de Almeida JR, et al. Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy-a multicenter collaborative cohort study. Oral Oncol. 2022;134(106089):1-7.
Bresson K, Rasmussen H, Rasmussen PA. Pharyngo-cutaneous fistulae in totally laryngectomized patients. J Laryngol Otol. 1974;88(9):835-842.
Dong YB, Yuan LN, Luo JK, et al. Delayed oral feeding reduces pharyngocutaneous fistula formation after open surgical treatment of primary hypopharyngeal cancer: a case-control study. Ear Nose Throat J. 2022;11(7):1-7.
Tsou YA, Hua CH, Lin MH, Tseng HC, Tsai MH, Shaha A. Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharyngectomy and salvage laryngopharyngectomy for advanced hypopharyngeal cancer. Head Neck. 2010;32(11):1494-1500.
Siegwart LC, Tapking C, Diehm YF, et al. The use of closed incision negative pressure therapy on the medial thigh donor site in transverse musculocutaneous gracilis flap breast reconstruction. J Clin Med. 2022;11(10):1-10.
Astasio-Picado Á, Montero M, López-Sánchez M, Jurado-Palomo J, Cobos-Moreno P, Gómez-Martín B. The effectiveness of negative pressure therapy: nursing approach. J Pers Med. 2022;12(11):1-17.
Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38(6):563-576.
Loske G, Müller J, Braun L, et al. Transabdominal esophago-cutaneous fistula closure with endoscopic negative pressure therapy using a thin open-pore film drain in a pull-through technique. Endoscopy. 2023;55(1):173-174.
Loske G, Schulze W, Kiesow RU, Kurzidem M, Fernandez DLMS, Müller CT. First report of closure of an iatrogenic recto-vesical fistula solely using endoscopic negative pressure therapy. Endoscopy. 2022;54(2):879-881.
Popivanov G, Cirocchi R, Penchev D, Kjossev K, Konaktchieva M, Mutafchiyski V. Successful negative pressure therapy of enteroatmospheric fistula after right colectomy for complicated Crohn's disease-a proposal for a three-drain wound-separation technique. Medicina (Kaunas). 2022;58(2):1-7.
Loske G, Müller J, Röske A, Majert D, Schulze W, Mueller CT. Closure of a duodenal cutaneous fistula with endoscopic negative pressure therapy using a thin open-pore film drain-an easy tool and simple method. Endoscopy. 2022;54(9):490-491.
Mudry A, Laccourreye O. 150 years ago: first complete removal of the larynx by Theodor Billroth. Eur Ann Otorhinolaryngol Head Neck Dis. 2023;140(1):49-52.
Gussenbauer C, Billroth T. Menschen ausgeführte Kehlkopf-Extirpation und die Anwendung eines kunstlichen Kehlkopfes. Arch Klin Chir. 1874;17(1):343-356.
Laccourreye O, Garcia D, Mudry A. Total laryngectomy for laryngeal cancer 150 years after its first description: a boon more than a calamity: a STROBE analysis. Eur Ann Otorhinolaryngol Head Neck Dis. 2023;140(1):25-29.
Casasayas M, Sansa A, García-Lorenzo J, Venegas M, Quer M, León X. Pharyngocutaneous fistula in irradiated patients: systematic review and our experience. J Laryngol Otol. 2022;136(11):1027-1033.
Cavalot AL, Gervasio CF, Nazionale G, et al. Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg. 2000;123(5):587-592.
Chotipanich A, Wongmanee S. Incidence of pharyngocutaneous fistula after total laryngectomy and its relationship with the shapes of mucosa closure: a meta-analysis. Cureus. 2022;14(9):e28822.
Matsumoto S, Nakayama M, Gosho M, et al. Inflammation-based score (combination of platelet count and neutrophil-to-lymphocyte ratio) predicts pharyngocutaneous fistula after total laryngectomy. Laryngoscope. 2022;132(8):1582-1587.
Cohen J, Reed W, Foster MW, et al. Octreotide may improve pharyngocutaneous fistula healing through downregulation of cystatins: a pilot study. Laryngosc Investig Otolaryngol. 2023;8(1):113-119.
Bril SI, Chargi N, Pezier TF, et al. Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy. Head Neck. 2022;44(2):307-316.
Galli J, De Corso E, Volante M, Almadori G, Paludetti G. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Otolaryngol Head Neck Surg. 2005;133(5):689-694.
Marchese MR, Di Cesare T, De Corso E, Petracca M, Oliveto G, Almadori G. Botulinum neurotoxin a in the treatment of pharyngocutaneous fistula after salvage surgery in head and neck cancer patients: our preliminary results. Curr Oncol. 2022;29(10):7099-7105.
Molteni G, Sacchetto A, Sacchetto L, Marchioni D. Optimal management of post-laryngectomy pharyngo-cutaneous fistula. Open Access Surgery. 2020;13(1):11-25.
Magdy EA. Surgical closure of postlaryngectomy pharyngocutaneous fistula: a defect based approach. Eur Arch Otorhinolaryngol. 2008;265(1):97-104.
Abu ER, Eviatar E, Gavriel H. Hyperbaric oxygen therapy as an alternative to surgery for non-healing pharyngocutaneous fistula. Eur Arch Otorhinolaryngol. 2016;273(11):3857-3861.
Rodrigues NC, Buskermolen J, Roffel S, et al. Human saliva stimulates skin and oral wound healing in vitro. J Tissue Eng Regen Med. 2019;13(6):1079-1092.
Oudhoff MJ, Bolscher JG, Nazmi K, et al. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 2008;22(11):3805-3812.
White HN, Golden B, Sweeny L, Carroll WR, Magnuson JS, Rosenthal EL. Assessment and incidence of salivary leak following laryngectomy. Laryngoscope. 2012;122(8):1796-1799.
Gall AM, Sessions DG, Ogura JH. Complications following surgery for cancer of the larynx and hypopharynx. Cancer Am Cancer Soc. 1977;39(2):624-631.
Montgomery WW. Salivary bypass tube. Ann Otol Rhinol Laryngol. 1978;87(2):159-162.
Costantino A, Pace GM, Festa BM, et al. Salivary bypass tube in total laryngectomy: systematic review and meta-analysis. Head Neck. 2022;44(11):2608-2620.
Bohlok A, Richet T, Quiriny M, et al. The effect of salivary bypass tube use on the prevention of pharyngo-cutaneous fistulas after total laryngectomy. Eur Arch Otorhinolaryngol. 2022;279(1):311-317.
Bitter T, Pantel M, Dittmar Y, Guntinas-Lichius O, Wittekindt C. Stent migration to the ileum: a potentially lethal complication after montgomery salivary bypass tube placement for hypopharyngeal stenosis after laryngectomy. Head Neck. 2012;34(1):135-137.
Hone R, Rahman E, Wong G, et al. Do salivary bypass tubes lower the incidence of pharyngocutaneous fistula following total laryngectomy? A retrospective analysis of predictive factors using multivariate analysis. Eur Arch Otorhinolaryngol. 2017;274(4):1983-1991.
Inman JC, Kim P, McHugh R. Retroesophageal subclavian artery-esophageal fistula: a rare complication of a salivary bypass tube. Head Neck. 2008;30(8):1120-1123.
Marchese MR, Almadori G, Giorgio A, Paludetti G. Post-surgical role of botulinum toxin-a injection in patients with head and neck cancer: personal experience. Acta Otorhinolaryngol Ital. 2008;28(1):13-16.
Liebman RM, Hanubal KS, Dziegielewski PT. Negative pressure wound therapy in the head and neck: a summary of uses and application techniques. Semin Plast Surg. 2023;37(1):9-18.
Inatomi Y, Kadota H, Yoshida S, et al. Utility of negative-pressure wound therapy for orocutaneous and pharyngocutaneous fistula following head and neck surgery. Head Neck. 2020;42(1):103-110.
Teixeira S, Costa J, Bartosch I, Correia B, Silva Á. Management of pharyngocutaneous fistula with negative-pressure wound therapy. J Craniofac Surg. 2017;28(4):364-367.
Zhang X, Liu F, Lan X, Luo K, Xiao F, Li S. Continuous negative pressure-flush through a dual tube for the treatment of a complicated pharyngeal fistula: a case report. Oncol Lett. 2016;11(3):1815-1818.
Marouf A, Mortada H, Khedr B, Halawani L, Zino AS, Alghamdi H. Effectiveness and safety of immediate application of negative pressure wound therapy in head and neck free flap reconstruction: a systematic review. Br J Oral Maxillofac Surg. 2022;60(8):1005-1011.
Loeck J, von Lücken HJ, Kehrl W, Loske G. Endoscopic negative pressure therapy (ENPT) of a post-laryngectomy pharyngocutaneous fistula: first report of a new treatment method. HNO. 2019;67(2):77-79.
Davies JC, Hugh S, Rich JT, et al. Association of pharyngocutaneous fistula with cancer outcomes in patients after laryngectomy: a multicenter collaborative cohort study. JAMA Otolaryngol Head Neck Surg. 2021;147(12):1027-1034.
Lansaat L, van der Noort V, Bernard SE, et al. Predictive factors for pharyngocutaneous fistulization after total laryngectomy: a Dutch head and neck society audit. Eur Arch Otorhinolaryngol. 2018;275(3):783-794.
Ganly I, Patel S, Matsuo J, et al. Postoperative complications of salvage total laryngectomy. Cancer Am Cancer Soc. 2005;103(10):2073-2081.
Grandis JR, Snyderman CH, Johnson JT, Yu VL, D'Amico F. Postoperative wound infection. A poor prognostic sign for patients with head and neck cancer. Cancer Am Cancer Soc. 1992;70(8):2166-2170.
González-Márquez R, Rodrigo JP, Suárez NC. Prognostic significance of postoperative wound infections after total laryngectomy. Head Neck. 2012;34(7):1023-1027.

Auteurs

Zhangwei Hu (Z)

Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.

Xueqin Guo (X)

Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.

Lin Chen (L)

Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.

Wenbin Lei (W)

Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Otorhinolaryngology Institute, Sun Yat-sen University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH